Nick Conley

What if we embrace bacteria as agents of health and survival rather than agents of disease?

Share This Talk

Have a suggestion for The Hive?
Submit a Nomination Today

About Nick Conley

Nick Conley is Co-Founder and CEO of EpiBiome. He completed a PhD in Chemistry and a postdoctoral fellowship in Developmental Biology at Stanford University. In addition to working at Stanford University with Professor W. E. Moerner, winner of the 2014 Nobel Prize in Chemistry, Nick was a Beckman Fellow, a National Science Foundation Graduate Research Fellow, a Lieberman Fellow, a Stanford Molecular Imaging Scholars Fellow, and a Younger Fellow. He has published 18 peer-reviewed journal articles and he holds 4 US patents. Prior to co-founding EpiBiome, Nick was a Research Staff Member at HGST, a Western Digital Company. He has also co-founded several successful companies in the oral and skincare space.

Find out more

About This Idea

EpiBiome is a venture-backed precision microbiome engineering company working to curb the growing threat of multi-drug-resistant "superbugs" by eliminating the use of shared-class antibiotics (those shared between humans and animals) from agriculture. Instead of antibiotics, the company deploys bacteria-specific viruses that are abundant in nature and harmless to humans to treat bacterial infections. The company has garnered numerous awards and accolades, including: acceptance into the inaugural class of Illumina Accelerator; winning Johnson & Johnson’s Quick Fire Challenge; acceptance into Springboard Accelerator; winning a Bill & Melinda Gates Foundation Grand Challenges Explorations Grant; advancing from 480 companies to the final 3 in the SXSW Accelerator at the Interactive Festival; admission into StartX, Stanford’s stage-agnostic accelerator; and, most recently, winning BIO’s “Buzz of BIO” in the “Technologies of Tomorrow” category.

Find out more

More Talks from the Hive

These talks are all a part of special session at TEDMED, called "Audacious" where we invite our innovators to take the stage and share the central idea they are working on, in short 2-minute talks. These talks are creatively grouped by 4 mini-segments, that serves as a creative link between each talk. To find out more visit The Hive page.